Cyanotech Corp (OTCPK:CYAN)
$ 0.49 +0.030 (+6.52%) Market Cap: 3.55 Mil Enterprise Value: 14.88 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 23/100

Q4 2025 Cyanotech Corp Earnings Call Transcript

Jun 23, 2025 / 12:00 AM GMT
Release Date Price: $0.352

Key Points

Positve
  • Cyanotech Corp (CYAN) reported a 5% growth in net sales for the fiscal year 2025.
  • The company achieved an 11% improvement in expenses due to efficiencies in production and tight inventory management.
  • Bulk spirulina and Bulkasa Xanthin sales grew significantly by 53% and 74% respectively.
  • Gross profit margin improved to 28.4% for the fiscal year, up from 25.8% the previous year.
  • Operating loss for the fiscal year decreased to $2.5 million from $4.6 million in the prior year.
Negative
  • Net loss for the fiscal year was $3.2 million, although reduced from the previous year's $5.3 million.
  • Cash reserves decreased to $257,000 at the end of the fiscal year, down from $707,000 the previous year.
  • Working capital also declined to $302,000 from $2 million at the end of fiscal year 2024.
  • Package sales declined by about 5%, offsetting some of the gains in bulk product sales.
  • Despite improvements, the company still reported a net loss per diluted share of $0.45 for the fiscal year.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CYAN.PK - Cyanotech Corp
Q4 2025 Cyanotech Corp Earnings Call
Jun 24, 2025 / 12:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Aloha from Kona, Hawaii.

Thank you all for joining us today to report SinoTech's 4th quarter and fiscal year 2025 earnings results. I'm Matt Custer, President and Chief Executive Officer of Sinotech. Joining me on the call today is Jennifer Rogerson, our Chief Financial Officer. I will turn the call over to Jennifer to provide our forward-looking statement.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks, Matt. Our discussion today may include forward-looking statements. We do not undertake any obligation to update forward-looking statements either as a result of new
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot